AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31247132
Drug: CBD capsules
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CBD capsules administered with food (high fat 840‐860 calorie)
Trial: 31247132
Drug: CBD capsules
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CBD capsules administered without food (fasting)
Trial: 29254862
Drug: Ceftazidime-avibactam (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime-avibactam (2000 mg ceftazidime and 500 mg avibactam by 2 h intravenous infusion every 8 h for 7-14 days)
Trial: 29254862
Drug: Meropenem (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem (1000 mg by 30-min intravenous infusion every 8 h for 7-14 days)
Trial: 22648717
Drug: Magnesium (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium (300 mg/d)
Trial: 16523808
Drug: Radiotherapy dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy dose escalation
Trial: 22770932
Drug: Protein supplementation
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein supplementation (2 * 15 g, twice daily)
Trial: 19509020
Drug: Low-dose cortisol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cortisol infusion (physiologic levels during hypoglycemia)
Trial: 19509020
Drug: High-dose cortisol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cortisol infusion (twofold greater elevations of plasma cortisol)
Trial: 19509020
Drug: Hypoglycemic clamps
RxNorm normalized name: CLAMP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoglycemic clamps (2.9 mmol/l)
Trial: 19509020
Drug: Euglycemic clamps
RxNorm normalized name: CLAMP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euglycemic clamps (5.1 mmol/l)
Trial: 10093945
Drug: Ofloxacin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (10 mg/kg/day in two divided doses for 5 days)
Trial: 10093945
Drug: Cefixime (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime (20 mg/kg/day in two divided doses for 7 days)
Trial: 7486178
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (0.15, 0.45, 1.5 ppm)
Trial: 7486178
Drug: Intravenous almitrine
RxNorm normalized name: almitrine
DrugBank: Almitrine (DB01430)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous almitrine (16 micrograms.kg-1.min-1)
Trial: 7486178
Drug: Almitrine plus
RxNorm normalized name: almitrine
DrugBank: Almitrine (DB01430)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrine plus inhaled nitric oxide (1.5 ppm)
Trial: 2030370
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day tetrahydroaminoacridine (THA) and 10 g/day lecithin
Trial: 7044195
Drug: Fluocortin butylester
RxNorm normalized name: fluocortin
DrugBank: Fluocortin (DB13223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluocortin butylester (FCB) 4 mg
Trial: 31846014
Drug: Rocuronium (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (1.2 mg/kg)
Trial: 19387176
Drug: Succinylcholine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinylcholine (1 mg/kg)
Trial: 28705122
Drug: Mobile application
RxNorm normalized name: Mahana IBS CBT Mobile Application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobile application with active reminders of oral hygiene (3 times a day)
Trial: 28705122
Drug: Verbal oral
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verbal oral hygiene instructions
Trial: 16550733
Drug: Bosentan 125
RxNorm normalized name: bosentan 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bosentan 125 mg b.i.d. for 7 days plus norethisterone and ethinyl estradiol on Day 7
Trial: 16550733
Drug: OrthoNovum containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OrthoNovum containing 1 mg norethisterone and 35 microg ethinyl estradiol
Trial: 10880410
Drug: Bezafibrate (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate (400 mg per day)
Trial: 9234037
Drug: Buspirone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (15 mg/70 kg)
Trial: 9234037
Drug: Buspirone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (30 mg/70 kg)
Trial: 9234037
Drug: Alprazolam (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (0.75 mg/70 kg)
Trial: 9234037
Drug: Alprazolam (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (1.5 mg/70 kg)
Trial: 9234037
Drug: Buspirone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (15 mg/70 kg) + Ethanol (0‐0.6 g/kg)
Trial: 9234037
Drug: Buspirone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (30 mg/70 kg) + Ethanol (0‐0.6 g/kg)
Trial: 9234037
Drug: Alprazolam (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (0.75 mg/70 kg) + Ethanol (0‐0.6 g/kg)
Trial: 9234037
Drug: Alprazolam (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (1.5 mg/70 kg) + Ethanol (0‐0.6 g/kg)
Trial: 9234037
Drug: Ethanol (0‐0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0‐0.6 g/kg)
Trial: 3980799
Drug: Suberythemogenic doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suberythemogenic doses of ultraviolet B (UVB) radiation with tar oil
Trial: 11754126
Drug: Intravenous clomipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous clomipramine (IV CMI) 25 mg increasing to 250 mg by day 10, continuing to day 14
Trial: 11754126
Drug: Intravenous clomipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous clomipramine (IV CMI)
Trial: 8514538
Drug: Topical ascorbic
RxNorm normalized name: ascorbic acid Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ascorbic acid solution applied twice per day during radiotherapy
Trial: 8514538
Drug: Vehicle (placebo)
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle (placebo) applied twice per day during radiotherapy
Trial: 28704584
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of solifenacin 5 mg + mirabegron 25 mg
Trial: 28704584
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of solifenacin 5 mg + mirabegron 50 mg
Trial: 17989547
Drug: Rehydration with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehydration with approximately 1 l fluid for minor surgical procedures; 1-3 l fluid for moderate surgical procedures (laparoscopic surgery)
Trial: 17989547
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of a carbohydrate-rich beverage preoperatively
Trial: 15891265
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg) given twice daily for 14 days
Trial: 15891265
Drug: Nizatidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine (150 mg) given twice daily for 14 days
Trial: 27322159
Drug: Twice-weekly peer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly peer play psychotherapy (PPP)
Trial: 27322159
Drug: Higher dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dosage of PPP
Trial: 25640290
Drug: Immediate-release oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release oxycodone
Trial: 15454247
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for advanced disease
Trial: 15454247
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy for colorectal cancer
Trial: 27343685
Drug: hf-tRNS with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hf-tRNS with no concurrent training
Trial: 24636027
Drug: Povidone-iodine soaks
RxNorm normalized name: Povidone-Iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone-iodine soaks 3 times daily
Trial: 24636027
Drug: Daily dressing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dressing changes
Trial: 19205545
Drug: Rosuvastatin 40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 40 mg daily
Trial: 18175337
Drug: Sarizotan (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarizotan (2 mg/day)
Trial: 12889719
Drug: Adapalene solution
RxNorm normalized name: Adapalene
DrugBank: Adapalene (DB00210)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adapalene solution 0.1%
Trial: 12889719
Drug: Tazarotene gel
RxNorm normalized name: Tazarotene
DrugBank: Tazarotene (DB00799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tazarotene gel 0.1%
Trial: 12889719
Drug: Tazarotene gel
RxNorm normalized name: Tazarotene
DrugBank: Tazarotene (DB00799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tazarotene gel 0.05%
Trial: 8896124
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid 500 mg/6 h
Trial: 12317784
Drug: Clindamycin phosphate
RxNorm normalized name: Clindamycin Phosphate
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clindamycin phosphate vaginal cream 2%, 5 grams intravaginally at bedtime
Trial: 12317784
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole capsules, 500 mg, taken twice daily
Trial: 31633778
Drug: BF plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BF plus CMF group (breastfeeding supplemented with cow's milk formula ≥5 mL/d from the first day of life to 5 months of age)
Trial: 15473497
Drug: Concurrent QL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent QL estimates
Trial: 12441903
Drug: Applying a
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Applying a topical anti-infective cream or ointment or a chlorhexidine-impregnated dressing to the insertion site
Trial: 9391222
Drug: Slow-release nifedipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release nifedipine 30 mg orally
Trial: 2296931
Drug: Single, oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single, oral high dose of vitamin A (n = 65)
Trial: 7043710
Drug: Indomethacin sustained-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin sustained-release 75 mg capsule b.i.d.
Trial: 7043710
Drug: Conventional indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional indomethacin 50 mg capsule t.i.d.
Trial: 29543933
Drug: 79.2 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 79.2 Gy radiation therapy
Trial: 29543933
Drug: 70.2 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70.2 Gy radiation therapy
Trial: 26135754
Drug: Methylprednisolone (MP)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MP) 25 mg IV for the first week, decreasing to 12.5 mg during the 2nd week until birth
Trial: 26135754
Drug: Placebo (PL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PL) matching IV treatment
Trial: 25288473
Drug: Gonadotropin-releasing hormone
RxNorm normalized name: Gonadotropin-releasing hormone
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gonadotropin-releasing hormone antagonist (GnRH-ant)
Trial: 25288473
Drug: Gonadotropin-releasing hormone
RxNorm normalized name: Gonadotropin-releasing hormone
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gonadotropin-releasing hormone agonist (GnRH-a)
Trial: 19859806
Drug: Higher dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dosage of All Stars
Trial: 19859806
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of higher dosage and higher quality delivery of All Stars
Trial: 15550992
Drug: Tacrolimus ointment
RxNorm normalized name: Tacrolimus Ointment
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus ointment (Protopic)
Trial: 11748093
Drug: Etanercept (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (25 mg subcutaneous injection)
Trial: 8332271
Drug: Enoximone (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone (Group C: 0.5 mg/kg bolus and slow infusion at 10 gamma/kg/min)
Trial: 2437095
Drug: Acyclovir for
RxNorm normalized name: Acyclovir for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir for five days and levamisole twice weekly for three weeks
Trial: 24813561
Drug: Macitentan 30
RxNorm normalized name: Macitentan
DrugBank: Macitentan (DB08932)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Macitentan 30 mg
Trial: 22274809
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily gonadotropin administration
Trial: 19358785
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of the same medications after acute treatment (mood stabilizer plus antidepressant) for 1 year
Trial: 15870414
Drug: Single high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high-dose bolus tirofiban plus sirolimus-eluting stenting (n = 87)
Trial: 15870414
Drug: Standard-dose abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose abciximab plus bare-metal stenting (n = 88)
Trial: 15870414
Drug: Single high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high-dose bolus tirofiban plus sirolimus-eluting stenting
Trial: 15870414
Drug: Standard-dose abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose abciximab plus bare-metal stenting
Trial: 9927831
Drug: Diltiazem (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (0.15 mg/kg intravenous dose followed by infusion of 3 micrograms/kg/min for 3 hours)
Trial: 31116189
Drug: Suturing plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suturing plus leukocyte- and platelet-rich fibrin (L-PRF) plug
Trial: 24026598
Drug: Prednisolone +
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone + Pentoxifylline (40 mg prednisolone once a day and 400 mg pentoxifylline 3 times a day for 28 days)
Trial: 24026598
Drug: Prednisolone +
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone + Placebo (40 mg prednisolone and matching placebo for 28 days)
Trial: 11228275
Drug: Org31540/SR90107A 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org31540/SR90107A 0.75 mg
Trial: 11228275
Drug: Org31540/SR90107A 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org31540/SR90107A 1.5 mg
Trial: 11228275
Drug: Org31540/SR90107A 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org31540/SR90107A 3.0 mg
Trial: 11228275
Drug: Org31540/SR90107A 6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org31540/SR90107A 6.0 mg
Trial: 11228275
Drug: Org31540/SR90107A 8.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org31540/SR90107A 8.0 mg
Trial: 11228275
Drug: Enoxaparin 30
RxNorm normalized name: ENOXAPARIN 30MG/0.3ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 30 mg every 12 hours
Trial: 7815836
Drug: All-trans retinoic
RxNorm normalized name: all trans Retinoic acid
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All-trans retinoic acid (ATRA) followed by intensive chemotherapy
Trial: 1325513
Drug: Spirapril 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 12.5 mg
Trial: 1325513
Drug: Spirapril 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 25 mg
Trial: 28695606
Drug: Chrysin 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chrysin 50 mg/day
Trial: 28695606
Drug: Chrysin 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chrysin 75 mg/day
Trial: 23856657
Drug: Treatment modalities
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment modalities (specific modalities not detailed)
Trial: 21873253
Drug: 2-L polyethylene
RxNorm normalized name: Iron(2+) L-ascorbate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-L polyethylene glycol (PEG)
Trial: 17030532
Drug: 7-day antibiotic
RxNorm normalized name: Antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day antibiotic therapy (n = 34)
Trial: 17030532
Drug: 14-day antibiotic
RxNorm normalized name: Antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-day antibiotic therapy (n = 35)
Trial: 17030532
Drug: 7-day therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day therapy for Staphylococcus aureus infection (n = 7)
Trial: 17030532
Drug: 14-day therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 14-day therapy for Staphylococcus aureus infection (n = 7)
Trial: 17030532
Drug: 7-day therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day therapy for non-S. aureus infections
Trial: 17030532
Drug: 14-day therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 14-day therapy for non-S. aureus infections
Trial: 9595966
Drug: Metrifonate (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate (0.5 mg/kg, 0.9 mg/kg, or 2.0 mg/kg for 2 weeks followed by maintenance doses of 0.2 mg/kg, 0.3 mg/kg, or 0.65 mg/kg for 10 weeks)
Trial: 6340583
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of gentamicin sulfate and betamethasone phosphate
Trial: 29385007
Drug: Alcohol (1.09
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (1.09 g ethanol·kg fat-free body mass)
Trial: 28336242
Drug: Pacritinib 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pacritinib 400 mg once daily
Trial: 24077205
Drug: Pregabalin 50
RxNorm normalized name: pregabalin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 50 mg every 8 hours orally (P group)
Trial: 24077205
Drug: Pregabalin 25
RxNorm normalized name: pregabalin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 25 mg every 8 hours orally and Imipramine 5 mg every 12 hours orally (P-I group)
Trial: 24077205
Drug: Pregabalin 25
RxNorm normalized name: pregabalin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 25 mg every 8 hours orally and Mirtazapine 7.5 mg every 12 hours orally (P-M group)
Trial: 21430242
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g of NSP plus 22 g of RS/d
Trial: 21430242
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g of NSP
Trial: 12907008
Drug: PnCRM7 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PnCRM7 vaccine
Trial: 11573049
Drug: Epidural anesthesia
RxNorm normalized name: Epidural Anesthesia Tray
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural anesthesia and postoperative epidural morphine (group 2)
Trial: 11573049
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia and postoperative analgesia with parenteral opioids (group 1)
Trial: 10095403
Drug: Non-operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-operative treatment (group B)
Trial: 10095403
Drug: Non-operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-operative treatment (group D)
Trial: 10095403
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (group C)
Trial: 7845808
Drug: Steroid membrane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid membrane leads (30 micrograms of dexamethasone)
Trial: 3621988
Drug: Naproxen (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (750 mg daily)
Trial: 582710
Drug: Indometacin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indometacin (150 mg daily)